The ability of whole serum to promote cell cholesterol efflux and the relationships between apoprotein and lipoprotein components of human serum efflux have been investigated previously (de la Llera Moya, M., V. Atger, J.L. Paul, N. Fournier, N. Moatti, P. Giral, K.E. Friday, and G.H. Rothblat. 1994. Arterioscler. Thromb. 14:1056-1065). We have now used this experimental system to study the selective effects of two human lipoprotein-related proteins, apoprotein AI (apo AI) and cholesteryl ester transfer protein (CETP) on cell cholesterol efflux, when these proteins are expressed in transgenic mice. The percent efflux values for cholesterol released in 4 h from Fu5AH donor cells to 5% sera from the different groups of mice were in the order: background = human apo AI transgenic (HuAITg) > human CETP transgenic (HuCETPTg) > human apo AI and CETP transgenic (HuAICETPTg) >> apo AI knockout mice. In each group of mice a strong, positive correlation (r2 ranging from 0.64 to 0.76) was found between efflux and HDL cholesterol concentrations. The slopes of these regression lines differed between groups of mice, indicating that the cholesterol acceptor efficiencies of the sera differed among groups. These differences in relative efficiencies can explain why cholesterol efflux was not proportional to the different HDL levels in the various groups of mice. We can conclude that: (a) HDL particles from HuAITg mice are less efficient as cholesterol acceptors than HDL from the background mice; (b) despite a lower average efflux due to lower HDL cholesterol concentrations, HDL particles are more efficient in the HuCETPTg mice than in the background mice; and (c) the coexpression of both human apo AI and CETP improves the efficiency of HDL particles in the HuAICETPTg mice when compared with the HuAITg mice. We also demonstrated that the esterification of the free cholesterol released from the cells by lecithin cholesterol acyltransferase in the serum was reduced in the HuAITg and AI knockout mice, whereas it was not different from background values in the two groups of mice expressing human CETP.
V Atger, M de la Llera Moya, M Bamberger, O Francone, P Cosgrove, A Tall, A Walsh, N Moatti, G Rothblat
Title and authors | Publication | Year |
---|---|---|
Human cholesteryl ester transport protein transgene promotes macrophage reverse cholesterol transport in C57BL/6 mice and phospholipid transfer protein gene knockout mice
N Liu, Y Si, Y Zhang, S Guo, S Qin |
Journal of Physiology and Biochemistry | 2021 |
A critical appraisal of the measurement of serum ‘cholesterol efflux capacity’ and its use as surrogate marker of risk of cardiovascular disease
M Anastasius, C Luquain-Costaz, M Kockx, W Jessup, L Kritharides |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2018 |
Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport
ME Fernández-Suárez, JC Escolà-Gil, O Pastor, A Dávalos, F Blanco-Vaca, MA Lasunción, J Martínez-Botas, D Gómez-Coronado |
Scientific Reports | 2016 |
Targeting adipose tissue via systemic gene therapy
SM O'Neill, C Hinkle, SJ Chen, A Sandhu, R Hovhannisyan, S Stephan, WR Lagor, RS Ahima, JC Johnston, MP Reilly |
Gene Therapy | 2014 |
HDL-targeted therapies: progress, failures and future
BA Kingwell, MJ Chapman, A Kontush, NE Miller |
Nature Reviews Drug Discovery | 2014 |
Humans With Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase
B Shao, C Tang, A Sinha, PS Mayer, GD Davenport, N Brot, MN Oda, XQ Zhao, JW Heinecke |
Circulation research | 2014 |
Macrophage-Independent Regulation of Reverse Cholesterol Transport by Liver X Receptors
SR Breevoort, J Angdisen, IG Schulman |
Arteriosclerosis, thrombosis, and vascular biology | 2014 |
Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice
DT Valenta, JJ Bulgrien, CL Banka, LK Curtiss |
Atherosclerosis | 2006 |
Endothelial lipase: Its role in cardiovascular disease
ME Paradis, B Lamarche |
Canadian Journal of Cardiology | 2006 |
Endothelial lipase: its role in cardiovascular disease
ME Paradis, B Lamarche |
The Canadian journal of cardiology | 2006 |
Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes
D Masson, JP de Barros, Z Zak, T Gautier, NL Guern, M Assem, JW Chisholm, JR Paterniti, L Lagrost |
Journal of lipid research | 2005 |
Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1
JW Beulens, A Sierksma, A Tol, N Fournier, T Gent, JL Paul, HF Hendriks |
Journal of lipid research | 2004 |
Low High-Density Lipoprotein Cholesterol: Physiological Background, Clinical Importance and Drug Treatment
M Hersberger, A von Eckardstein |
Drugs | 2003 |
Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I–Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular Cholesterol Efflux
M Lee, L Calabresi, G Chiesa, G Franceschini, PT Kovanen |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
Arg123-Tyr166 domain of human ApoA-I is critical for HDL-mediated inhibition of macrophage homing and early atherosclerosis in mice
P Holvoet, K Peeters, S Lund-Katz, A Mertens, P Verhamme, R Quarck, D Stengel, M Lox, E Deridder, H Bernar, M Nickel, G Theilmeier, E Ninio, MC Phillips |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
High Density Lipoproteins and Arteriosclerosis: Role of Cholesterol Efflux and Reverse Cholesterol Transport
A von Eckardstein, JR Nofer, G Assmann |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
S Yamashita, T Maruyama, K Hirano, N Sakai, N Nakajima, Y Matsuzawa |
Atherosclerosis | 2000 |
Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein
S Yamashita |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2000 |
High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function
MN Rao, QH Liu, P Marmillot, LB Seeff, DB Strader, MR Lakshman |
Metabolism | 2000 |
High Density Lipoprotein Phospholipid Composition Is a Major Determinant of the Bi-directional Flux and Net Movement of Cellular Free Cholesterol Mediated by Scavenger Receptor BI
PG Yancey, M la Llera-Moya, S Swarnakar, P Monzo, SM Klein, MA Connelly, WJ Johnson, DL Williams, GH Rothblat |
The Journal of biological chemistry | 2000 |
Human ApoA-IV Overexpression in Transgenic Mice Induces cAMP-Stimulated Cholesterol Efflux From J774 Macrophages to Whole Serum
N Fournier, V Atger, JL Paul, M Sturm, N Duverger, GH Rothblat, N Moatti |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Remodelling of high density lipoproteins by plasma factors
KA Rye, MA Clay, PJ Barter |
Atherosclerosis | 1999 |
Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes
N Fournier, V Atger, JL Paul, ML la Moya, G Rothblat, N Moatti |
Atherosclerosis | 1999 |
Increased Cholesterol Efflux Potential of Sera From ApoA-I Milano Carriers and Transgenic Mice
G Franceschini, L Calabresi, G Chiesa, C Parolini, CR Sirtori, M Canavesi, F Bernini |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice
P Holvoet, S Danloy, E Deridder, M Lox, H Bernar, A Dhoest, D Collen |
Journal of Clinical Investigation | 1998 |
Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man
T Radeau, M Robb, P Lau, J Borthwick, R McPherson |
Atherosclerosis | 1998 |
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
M Dammerman, LA Sandkuijl, JL Halaas, W Chung, JL Breslow |
Annual Review of Nutrition | 1998 |
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
M Dammerman, LA Sandkuijl, JL Halaas, W Chung, JL Breslow |
Annual Review of Nutrition | 1998 |
Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice
G Chiesa, C Parolini, M Canavesi, N Colombo, C R Sirtori, R Fumagalli, G Franceschini, F Bernini |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
Sterol Regulatory Element Binding Protein-1 Activates the Cholesteryl Ester Transfer Protein Gene in Vivo but Is Not Required for Sterol Up-regulation of Gene Expression
RA Chouinard, Y Luo, TF Osborne, A Walsh, AR Tall |
The Journal of biological chemistry | 1998 |
Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells
VM Atger, ML la Moya, GW Stoudt, WV Rodrigueza, MC Phillips, GH Rothblat |
Journal of Clinical Investigation | 1997 |
Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice
O Stein, Y Dabach, G Hollander, M Ben-Naim, G Halperin, JL Breslow, Y Stein |
Proceedings of the National Academy of Sciences | 1997 |
The Role of Cholesteryl Ester Transfer Protein and Phospholipid Transfer Protein in the Remodeling of Plasma High-Density Lipoproteins
L Lagrost |
Trends in Cardiovascular Medicine | 1997 |
HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum
N Fournier, JL Paul, V Atger, A Cogny, T Soni, M de la Llera-Moya, G Rothblat, N Moatti |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
CETP and exchangeable apoproteins: common features in lipid binding activity
V M Bolaños-García, M Soriano-García, J Mas-Oliva |
Molecular and Cellular Biochemistry | 1997 |
Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes
OL Francone, L Royer, M Haghpassand |
Journal of lipid research | 1996 |
Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats
N Fournier, M de la Llera Moya, BF Burkey, JB Swaney, J Paterniti, N Moatti, V Atger, GH Rothblat |
Journal of lipid research | 1996 |